A New Style of Transplantation May Gain Points When Treating Older Patients with Acute Myeloid Leukemia

被引：2
作者：
Gerds, Aaron T. [1 ]
Mukherjee, Sudipto [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Leukemia & Myeloid Disorders Program, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 05期
关键词：
Acute myeloid leukemia; Microtransplantation; Decitabine; LOW-DOSE CYTARABINE; CHEMOTHERAPY; INDUCTION; AZACITIDINE; DECITABINE; INFUSION; PHASE-1; TRIAL; CARE; AML;
D O I：
10.1016/j.bbmt.2017.03.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：715 / 716
页数：2
相关论文
共 14 条
[1]   Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial [J].
Delaney, Colleen ;
Milano, Filippo ;
Cicconi, Laura ;
Othus, Megan ;
Becker, Pamela S. ;
Sandhu, Vicky ;
Nicoud, Ian ;
Dahlberg, Ann ;
Bernstein, Irwin D. ;
Appelbaum, Frederick R. ;
Estey, Elihu H. .
LANCET HAEMATOLOGY, 2016, 3 (07) :E330-E339
[2]   International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts [J].
Dombret, Herve ;
Seymour, John F. ;
Butrym, Aleksandra ;
Wierzbowska, Agnieszka ;
Selleslag, Dominik ;
Jang, Jun Ho ;
Kumar, Rajat ;
Cavenagh, James ;
Schuh, Andre C. ;
Candoni, Anna ;
Recher, Christian ;
Sandhu, Irwindeep ;
Bernal del Castillo, Teresa ;
Al-Ali, Haifa Kathrin ;
Martinelli, Giovanni ;
Falantes, Jose ;
Noppeney, Richard ;
Stone, Richard M. ;
Minden, Mark D. ;
McIntyre, Heidi ;
Songer, Steve ;
Lucy, Lela M. ;
Beach, C. L. ;
Doehner, Hartmut .
BLOOD, 2015, 126 (03) :291-299
[3]   Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia [J].
Goodyear, Oliver ;
Agathanggelou, Angelo ;
Novitzky-Basso, Igor ;
Siddique, Shamyla ;
McSkeane, Tina ;
Ryan, Gordon ;
Vyas, Paresh ;
Cavenagh, Jamie ;
Stankovic, Tanja ;
Moss, Paul ;
Craddock, Charles .
BLOOD, 2010, 116 (11) :1908-1918
[4]   Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients [J].
Guo, Mei ;
Hu, Kai-Xun ;
Yu, Chang-Lin ;
Sun, Qi-Yun ;
Qiao, Jian-Hui ;
Wang, Dan-Hong ;
Liu, Guang-Xian ;
Sun, Wan-Jun ;
Wei, Li ;
Sun, Xue-Dong ;
Huang, Ya-Jing ;
Qiao, Jun-Xiao ;
Dong, Zheng ;
Ai, Hui-Sheng .
BLOOD, 2011, 117 (03) :936-941
[5]   Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry [J].
Juliusson, Gunnar ;
Antunovic, Petar ;
Derolf, Asa ;
Lehmann, Soren ;
Mollgard, Lars ;
Stockelberg, Dick ;
Tidefelt, Ulf ;
Wahlin, Anders ;
Hoglund, Martin .
BLOOD, 2009, 113 (18) :4179-4187
[6]   Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia [J].
Kantarjian, Hagop M. ;
Thomas, Xavier G. ;
Dmoszynska, Anna ;
Wierzbowska, Agnieszka ;
Mazur, Grzegorz ;
Mayer, Jiri ;
Gau, Jyh-Pyng ;
Chou, Wen-Chien ;
Buckstein, Rena ;
Cermak, Jaroslav ;
Kuo, Ching-Yuan ;
Oriol, Albert ;
Ravandi, Farhad ;
Faderl, Stefan ;
Delaunay, Jacques ;
Lysak, Daniel ;
Minden, Mark ;
Arthur, Christopher .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2670-2677
[7]   Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia - A Randomised SAL Pilot Study [J].
Krug, Utz ;
Koschmieder, Anja ;
Schwammbach, Daniela ;
Gerss, Joachim ;
Tidow, Nicola ;
Steffen, Bjoern ;
Bug, Gesine ;
Brandts, Christian H. ;
Schaich, Markus ;
Roellig, Christoph ;
Thiede, Christian ;
Noppeney, Richard ;
Stelljes, Matthias ;
Buechner, Thomas ;
Koschmieder, Steffen ;
Duehrsen, Ulrich ;
Serve, Hubert ;
Ehninger, Gerhard ;
Berdel, Wolfgang E. ;
Mueller-Tidow, Carsten .
PLOS ONE, 2012, 7 (12)
[8]   Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML. [J].
Lancet, Jeffrey E. ;
Uy, Geoffrey L. ;
Cortes, Jorge E. ;
Newell, Laura F. ;
Lin, Tara L. ;
Ritchie, Ellen K. ;
Stuart, Robert K. ;
Strickland, Stephen Anthony ;
Hogge, Donna ;
Solomon, Scott R. ;
Stone, Richard M. ;
Bixby, Dale L. ;
Kolitz, Jonathan E. ;
Schiller, Gary J. ;
Wieduwilt, Matthew Joseph ;
Ryan, Daniel H. ;
Hoering, Antje ;
Chiarella, Michael ;
Louie, Arthur Chin ;
Medeiros, Bruno C. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[9]   Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia [J].
Qian, Si-Xuan ;
Li, Jian-Yong ;
Tian, Tian ;
Shen, Yun-Feng ;
Jiang, Yuan-Qiang ;
Lu, Hua ;
Wu, Han-Xin ;
Zhang, Su-Iiang ;
Xu, Wei .
LEUKEMIA RESEARCH, 2007, 31 (10) :1383-1388
[10]   Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML [J].
Scandura, Joseph M. ;
Roboz, Gail J. ;
Moh, Michelle ;
Morawa, Ewelina ;
Brenet, Fabienne ;
Bose, J. Robi ;
Villegas, Luis ;
Gergis, Usama S. ;
Mayer, Sebastian A. ;
Ippoliti, Cindy M. ;
Curcio, Tania J. ;
Ritchie, Ellen K. ;
Feldman, Eric J. .
BLOOD, 2011, 118 (06) :1472-1480
12